Yipinhong Pharmaceutical Co Ltd Class A - Asset Resilience Ratio

Latest as of March 2026: 0.66%

Yipinhong Pharmaceutical Co Ltd Class A (300723) has an Asset Resilience Ratio of 0.66% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥31.00 Million

≈ $4.54 Million USD Cash + Short-term Investments

Total Assets

CN¥4.70 Billion

≈ $687.40 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Yipinhong Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. Check Yipinhong Pharmaceutical Co Ltd Class A (300723) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Yipinhong Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Yipinhong Pharmaceutical Co Ltd Class A market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥31.00 Million	0.66%
Total Liquid Assets	CN¥31.00 Million	0.66%

Asset Resilience Insights

Limited Liquidity: Yipinhong Pharmaceutical Co Ltd Class A maintains only 0.66% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Yipinhong Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio

Compare Yipinhong Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Yipinhong Pharmaceutical Co Ltd Class A (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Yipinhong Pharmaceutical Co Ltd Class A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.11%	CN¥4.75 Million ≈ $694.52K	CN¥4.40 Billion ≈ $644.46 Million	-0.81pp
2023-12-31	0.92%	CN¥40.44 Million ≈ $5.92 Million	CN¥4.41 Billion ≈ $644.63 Million	-0.84pp
2022-12-31	1.76%	CN¥72.19 Million ≈ $10.56 Million	CN¥4.10 Billion ≈ $599.73 Million	+1.36pp
2021-12-31	0.41%	CN¥15.03 Million ≈ $2.20 Million	CN¥3.70 Billion ≈ $542.07 Million	-0.20pp
2020-12-31	0.61%	CN¥13.00 Million ≈ $1.90 Million	CN¥2.15 Billion ≈ $313.90 Million	-1.38pp
2019-12-31	1.98%	CN¥35.60 Million ≈ $5.21 Million	CN¥1.79 Billion ≈ $262.64 Million	--

pp = percentage points

About Yipinhong Pharmaceutical Co Ltd Class A

SHE:300723 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.32 Billion

CN¥15.85 Billion CNY

Market Cap Rank

#5606 Global

#1009 in China

Share Price

CN¥35.08

Change (1 day)

-0.62%

52-Week Range

CN¥29.56 - CN¥73.63

All Time High

CN¥80.53